Skip to main content
Log in

Proteolytic activity inSerratia marcescens clinical isolates

  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

Exoproteinase production was demonstrated in 64 clinical isolates ofS. marcescens. A significant relationship was found between the site of origin (autopsy material, hemocultures, various other sources), proteinase activity, and LD50 of the analyzed isolates. The number of exoproteinases varied during a 14-h incubation in batch cultures; the most frequently found was a 57.5-kDa proteinase which was observed in all analyzed strains. The exoproteinase production was shown to be related to strain virulence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abbot S.:Klebsiella, Enterobacter, Citrobacter, andSerratia, pp. 475–482 in P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds):Manual of Clinical Microbiology. ASM Press, Washington (DC) 1999.

    Google Scholar 

  • Aucken H.M., Pitt T.L.: Antibiotic resistance and putative virulence factors ofSerratia marcescens with respect to O and K serotypes.J.Med.Microbiol.47, 1195–1113 (1998).

    Google Scholar 

  • Bar-Ness R., Rosenberg M.: Putative role of a 70-kDa outer-surface protein in promoting cell-surface hydrophobicity ofSerratia marcescens RZ.J.Gen.Microbiol.135, 2277–2281 (1989).

    PubMed  CAS  Google Scholar 

  • Bogyiová E., Siegfried L., Kmeťová M., Šándorčínová Z., Liptáková A., Biroš E.: Occurrence and genetic association of selected virulence factors in clinicalEscherichia coli isolates.Folia Microbiol.47, 73–77 (2002).

    Article  Google Scholar 

  • Bollman R., Halle E., Sokolowska-Kohler W., Grauel E.L., Bucholz P., Klare I., Tshapé H., Witte W.: Nosocomial infections due toSerratia marcescens, clinical findings, antibiotic susceptibility patterns and fine typing.Infection17, 294–300 (1989).

    Article  Google Scholar 

  • Bromke B.J., Venuti E.: A basal-defined medium for the study of proteolytic activity ofSerratia marcescens.Can.J.Microbiol.45, 88–91 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Carbonell G.V., Fonseca B.A.L., Figuereido L.T.M., Darini A.L.C., Yanaguita R.M.: Culture conditions affect cytotoxin production bySerratia marcescens.FEMS Immunol.Med.Microbiol.16, 299–307 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Carbonell G.V., Vidotto M.C.: Virulence factors inSerratia marcescens: cell-bound hemolysin and aerobactin.Braz.J.Med.Biol.Res.25, 1–8 (1992).

    PubMed  CAS  Google Scholar 

  • Coria-Jiménez R., Ortiz-Torres C.: Aminoglycoside resistance ofSerratia marcescens strains of clinical origin.Epidemiol.Infect.112, 125–131 (1994).

    PubMed  Google Scholar 

  • Coria-Jiménez R., Romero-Olvera J., Celis-Cruz C.: Superficial hydrophobicity inSerratia marcescens strains of clinical origin.Res.Microbiol.149, 27–29 (1998).

    Article  PubMed  Google Scholar 

  • Dworniczek E., Kuzko K., Mróz E., Wojciech L., Adamski R., Sobieszczańska B., Seniuk A.: Virulence factors andin vitro adherence ofEnterococcus strains to urinary catheters.Folia Microbiol.48, 671–678 (2003).

    CAS  Google Scholar 

  • Farmer J.J.:Enterobacteriaceae: introduction and identification, pp. 442–458 in P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds):Manual of Clinical Microbiology, ASM Press, Washington (DC) 1999.

    Google Scholar 

  • Franiczek R., Sobieszczańska B., Grabowski M., Mowszet K., Pytrus T.: Occurrence of extended-spectrum β-lactamases amongEscherichia coli isolates from hospitalized and healthy children.Folia Microbiol.48, 243–248 (2003).

    CAS  Google Scholar 

  • Hejazi A., Falkiner F.R.:Serratia marcescens.J.Med.Microbiol.46, 903–912 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Hernández-Delgadillo R., Ruiz-Cruz J.J.: Actividad proteolítica libre deSerratia marcescens II. Cinética de producción y mecanismo de inducción.Rev.Lat-Amer.Microbiol.36, 93–100 (1994).

    Google Scholar 

  • Hertle R., Hilger M., Weingardt-Kocher S., Walev I.: Cytotoxic action ofSerratia marcescens hemolysin on human epithelial cells.Infect.Immun.67, 817–825 (1999).

    PubMed  CAS  Google Scholar 

  • Kamata R., Yamamoto T., Matsumoto K., Maeda H.: A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in Guinea pigs.Infect.Immun.48, 747–753 (1985).

    PubMed  CAS  Google Scholar 

  • Kim N., Kim S.I.: Characterization and primary specificity of an extracellular metalloproteinase fromSerratia marcescens.Can.J.Microbiol.40, 120–126 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Kunitz M.: Soybean trypsin inhibitor. II. General properties.J.Gen.Physiol.40, 291–310 (1947).

    Article  Google Scholar 

  • Lockwood B.C., North M.J., Scott K.I., Brenner A.F., Coomles G.H.: The use of a highly sensitive electrophoretic method to compare the proteinases of trichomonads.Mol.Biochem.Parasitol.24, 89–95 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Lyerly D., Gray L., Kreger A.: Characterization of rabbit corneal damage produced bySerratia keratitis andSerratia protease.Infect.Immun.31, 927–932 (1981).

    Google Scholar 

  • Lyerly D., Kreger A.: Importance ofSerratia proteases in the pathogenesis of experimentalSerratia marcescens pneumoniae.Infect.Immun.40, 113–119 (1983).

    PubMed  CAS  Google Scholar 

  • Majtánová L., Majtán V.: Postantibiotic effects of gentamicin and netilmicin onSerratia marcescens: effects on hydrophobicity and motility.Folia Microbiol.45, 45–50 (2000).

    Article  Google Scholar 

  • Matsumoto K., Maeda H., Takata T., Okamura R.: Purification and characterization of four proteases from clinical isolateSerratia marcescens KUMS 3958.J.Bacteriol.157, 225–232 (1984).

    PubMed  CAS  Google Scholar 

  • Molla A., Matsumoto A., Oyamada T., Katsuli T., Maeda H.: Degradation of protease inhibitors, immunoglobulins, and other serum proteins bySerratia protease and its toxicity to fibroblasts in culture.Infect.Immun.53, 522–529 (1986).

    PubMed  CAS  Google Scholar 

  • Molla A., Kagimoto T., Maeda H.: Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases fromSerratia marcescens.Infect.Immun.56, 916–920 (1988).

    PubMed  CAS  Google Scholar 

  • Montaner B., Navarro S., Pique M., Vilaseca M., Martinell M., Giralt E., Gil J., Perez-Tomas R.: Prodigiosin from the supernatant ofSerratia marcescens induces apoptosis in hematopoietic cancer cell lines.Brit.J.Pharmacol.131, 585–593 (2000).

    Article  CAS  Google Scholar 

  • Poole K., Braun B.: Iron regulation ofSerratta marcescens hemolysin gene expression.Infect Immun.56, 2967–2971 (1998).

    Google Scholar 

  • Reed L.J., Muench I.I.: A simple method for estimating fifty per cent endpoints.Amer.J.Hyg.27, 493–497 (1938).

    Google Scholar 

  • Schefler W.C.:Bioestadistica. Fondo Educativo Interamericano, México 1981.

    Google Scholar 

  • Yu V.L.:Serratia marcescens. Historical perspective and clinical review.New Engl.J.Med.300, 887–893 (1979).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Coria-Jiménez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coria-Jiménez, R., Zárate-Aquino, C. & Ponce-Ponce, O. Proteolytic activity inSerratia marcescens clinical isolates. Folia Microbiol 49, 321–326 (2004). https://doi.org/10.1007/BF02931050

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02931050

Keywords

Navigation